3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
1
Prolactinoma
1
Pituitary ACTH Hypersecretion
1
Paraproteinemias
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Mesothelioma, Malignant
1
Immunoglobulin Light-chain Amyloidosis
1
Head and Neck Neoplasms
1
Gigantism
1
Congenital Abnormalities
1
Combined Pituitary Hormone Deficiency
1
Carcinogenesis
1
Acromegaly
1
Interventions
pembrolizumab
44
Carboplatin
35
Paclitaxel
27
Specimen Handling
18
Cyclophosphamide
16
Capecitabine
16
Magnetic Resonance Spectroscopy
14
sacituzumab govitecan
13
Gemcitabine
13
Taxes
12
Biopsy
12
130-nm albumin-bound paclitaxel
11
Albumin-Bound Paclitaxel
9
Doxorubicin
8
olaparib
7
Nivolumab
7
fludarabine
6
Cisplatin
6
eribulin
5
atezolizumab
5
Radiotherapy
5
Docetaxel
5
durvalumab
4
Fulvestrant
4
Epirubicin
4
Bevacizumab
4
veliparib
3
famitinib
3
abemaciclib
3
Vinorelbine
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
Tissue Banks
×
90 days
×
Clear all
No trials found.